Abattis Bioceuticals Corp Stock Current Valuation
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Abattis Bioceuticals Corp helps investors to measure Abattis Bioceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Abattis Bioceuticals' price fluctuation is very steady at this time. Calculation of the real value of Abattis Bioceuticals Corp is based on 3 months time horizon. Increasing Abattis Bioceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Abattis Bioceuticals Corp is useful when determining the fair value of the Abattis pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Abattis Bioceuticals. Since Abattis Bioceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abattis Pink Sheet. However, Abattis Bioceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The real value of Abattis Pink Sheet, also known as its intrinsic value, is the underlying worth of Abattis Bioceuticals Corp Company, which is reflected in its stock price. It is based on Abattis Bioceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Abattis Bioceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abattis Bioceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abattis Bioceuticals Corp helps investors to forecast how Abattis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abattis Bioceuticals more accurately as focusing exclusively on Abattis Bioceuticals' fundamentals will not take into account other important factors: Abattis Bioceuticals Corp Company Current Valuation Analysis
Abattis Bioceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Abattis Bioceuticals Current Valuation | 4.08 M |
Most of Abattis Bioceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abattis Bioceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Abattis Bioceuticals Corp has a Current Valuation of 4.08 M. This is 99.97% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.98% higher than that of the company.
Abattis Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abattis Bioceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Abattis Bioceuticals could also be used in its relative valuation, which is a method of valuing Abattis Bioceuticals by comparing valuation metrics of similar companies.Abattis Bioceuticals is currently under evaluation in current valuation category among related companies.
Abattis Fundamentals
| Return On Equity | -0.28 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (10.96) % | |||
| Current Valuation | 4.08 M | |||
| Shares Outstanding | 477.8 M | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (5.83) X | |||
| Price To Book | 0.38 X | |||
| Price To Sales | 1.33 X | |||
| Revenue | 356.88 K | |||
| Gross Profit | 241.34 K | |||
| EBITDA | (2.9 M) | |||
| Net Income | (3.04 M) | |||
| Cash And Equivalents | 2.4 M | |||
| Total Debt | 150.86 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.73 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 9.41 M | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 32 | |||
| Beta | -60.6 | |||
| Market Capitalization | 473.03 K | |||
| Total Asset | 19.26 M | |||
| Retained Earnings | (10.13 M) | |||
| Working Capital | (588 K) | |||
| Current Asset | 260 K | |||
| Current Liabilities | 848 K | |||
| Z Score | 1.8 | |||
| Net Asset | 19.26 M |
About Abattis Bioceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abattis Bioceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abattis Bioceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abattis Bioceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Abattis Bioceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abattis Bioceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abattis Bioceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abattis Bioceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abattis Bioceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abattis Bioceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abattis Bioceuticals Corp to buy it.
The correlation of Abattis Bioceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abattis Bioceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abattis Bioceuticals Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abattis Bioceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abattis Bioceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Abattis Bioceuticals Corp information on this page should be used as a complementary analysis to other Abattis Bioceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Abattis Pink Sheet analysis
When running Abattis Bioceuticals' price analysis, check to measure Abattis Bioceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abattis Bioceuticals is operating at the current time. Most of Abattis Bioceuticals' value examination focuses on studying past and present price action to predict the probability of Abattis Bioceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abattis Bioceuticals' price. Additionally, you may evaluate how the addition of Abattis Bioceuticals to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |